Aspirin Exacerbated Asthma Recruiting Phase 2 Trials for Ifetroban (DB12321)

Also known as: Aspirin-sensitive asthma / Asthma Aspirin-sensitive / Asthma, Aspirin-Induced / Aspirin-induced asthma / Aspirin asthma / Aspirin-exacerbated respiratory disease / ASA - Aspirin-sensitive asthma triad

IndicationStatusPhase
DBCOND0057602 (Aspirin Exacerbated Asthma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03028350Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)Treatment
NCT03326063Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With IfetrobanTreatment